These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline]. Kuczyńska K, Zebrowski M, Kancelarczyk WL, Rymaszewski Z. Pol Tyg Lek; 1988 Aug 22; 43(34):1092-4. PubMed ID: 3075031 [No Abstract] [Full Text] [Related]
3. [The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study]. Regenthal R, Voigt H, Reuter W, Preiss R. Z Gesamte Inn Med; 1991 Apr 22; 46(6):185-90. PubMed ID: 2063598 [Abstract] [Full Text] [Related]
4. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs]. Berent H, Kancelarczyk WL, Zebrowski M, Uchman B. Pol Tyg Lek; 1988 Jun 13; 43(24):776-8. PubMed ID: 3237518 [No Abstract] [Full Text] [Related]
5. [Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders]. Cavaller JM, Samper JC. Med Monatsschr; 1976 Jul 13; 30(7):323-6. PubMed ID: 790140 [No Abstract] [Full Text] [Related]
9. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental. Chyzy R, Lukjan H, Rość D, Bielawiec M, Sawicka J. Folia Haematol Int Mag Klin Morphol Blutforsch; 1987 Jul 13; 114(4):549-54. PubMed ID: 2446996 [Abstract] [Full Text] [Related]
10. [Use of pentoxifylline (trental) to correct microcirculatory disorders in patients with atherosclerosis of peripheral arteries]. Atroshchenko ES. Kardiologiia; 1986 Dec 13; 26(12):106-8. PubMed ID: 3550207 [No Abstract] [Full Text] [Related]
11. Pentoxifylline--a new drug for the treatment of intermittent claudication. Chopra HK, Chopra KL, Aggarwal KK, Parashar SK. Indian Heart J; 1989 Dec 13; 41(2):127-33. PubMed ID: 2744799 [Abstract] [Full Text] [Related]
16. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease. Chopra HK, Chopra KL, Aggarwal KK, Parashar SK. J Med; 1988 Nov 21; 19(2):89-107. PubMed ID: 3049876 [Abstract] [Full Text] [Related]
17. Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses. Antignani PL, Todini AR, Saliceti F, Pacino G, Bartolo M. Pharmatherapeutica; 1987 Nov 21; 5(1):50-6. PubMed ID: 3602022 [Abstract] [Full Text] [Related]
18. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects. Reilly DT, Quinton DN, Barrie WW. N Z Med J; 1987 Jul 22; 100(828):445-7. PubMed ID: 3330188 [Abstract] [Full Text] [Related]
19. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs. Chacón-Quevedo A, Eguaras MG, Calleja F, Garcia MA, Roman M, Casares J, Muñoz I, Concha M. Angiology; 1994 Jul 22; 45(7):647-53. PubMed ID: 8024164 [Abstract] [Full Text] [Related]